ARTES brings new vaccine advances to veterinary ‘Dragons’ Den’

ARTES will attend February’s Euro­pean Ani­mal Health Invest­ment Forum in Lon­don and will present its inno­v­a­tive tech­nolo­gies to poten­tial part­ners
This will be ARTES’ sec­ond par­tic­i­pa­tion in the high pres­tige invest­ment net­work­ing event, which is seen as the ‘Drag­ons’ Den’ of vet­eri­nary med­i­cine.
ARTES Man­ag­ing Direc­tor, Dr. Michael Pio­ntek, will use the forum to talk with inter­est­ed par­ties about lat­est devel­op­ments of the laboratory’s inno­v­a­tive pro­pri­etary vac­cine devel­op­ment plat­form, METAVAX®, which received a new EU-based grant of patent last August.
Meet us at the Euro­pean Ani­mal Health Invest­ment Forum tak­ing place in Lon­don, Feb­ru­ary 20 -21. Con­tact us pre­vi­ous­ly for orga­niz­ing a per­son­al meet­ing or drop us a notice via the part­ner­ing sys­tem. We look for­ward to meet­ing you!